Risk prediction models of breast cancer: A systematic review of model performances

Breast Cancer Research and Treatment

Volumn 133, Issue 1, 2012, Pages 1-10

  Anothaisintawee, Thunyarat ^a   Teerawattananon, Yot ^b   Wiratkapun, Chollathip ^a   Kasamesup, Vijj ^a   Thakkinstian, Ammarin ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

Breast cancer; Risk prediction model; Systematic review

Indexed keywords

ACCURACY; BREAST CANCER; CALIBRATION; CANCER RISK; EXTERNAL VALIDITY; INTERNAL VALIDITY; LOGISTIC REGRESSION ANALYSIS; OBSERVATIONAL STUDY; POISSON REGRESSION; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; REVIEW; RISK FACTOR; RISK PREDICTION MODEL; SAMPLE SIZE; SYSTEMATIC REVIEW;

BREAST NEOPLASMS; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; MODELS, BIOLOGICAL; REGRESSION ANALYSIS; RISK FACTORS; ROC CURVE; VALIDATION STUDIES AS TOPIC;

EID: 84860341603     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1853-z     Document Type: Review

References (48)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics 2002 CA Cancer J Clinicians 55 2 74 108 10.3322/canjclin.55.2.74
2. Ferlay J, Bray F, Parkin DM, Pisani P eds (2001) Globalcan 2000. IARC Press, Lyon
3. VH BF (2002) IARC handbooks of cancer prevention. IARC Press, Lyon
4. Ries LAG EM, Kosary CL, et al. (2004) SEER cancer statistics review, 1975-2001. National Cancer Institute. http://seer.cancer.gov/csr/1975-2001/. Accessed Dec 22 2004
5. Steyerberg EW (ed) (2009) Clinical prediction models a practical approach to development, validation, and updating. Springer Science + Business Media LLC, New York
6. P Boyle M Mezzetti C La Vecchia S Franceschi A Decarli C Robertson 2004 Contribution of three components to individual cancer risk predicting breast cancer risk in Italy Eur J Cancer Prev 13 3 183 191 15167217 10.1097/01.cej.0000130014.83901.53 1:STN:280:DC%2BD2czksFWqsA%3D%3D (Pubitemid 38780674)
7. RT Chlebowski GL Anderson DS Lane AK Aragaki T Rohan S Yasmeen G Sarto CA Rosenberg FA Hubbell 2007 Predicting risk of breast cancer in postmenopausal women by hormone receptor status J Natl Cancer Inst 99 22 1695 1705 18000216 10.1093/jnci/djm224 1:CAS:528:DC%2BD1cXkslyksA%3D%3D (Pubitemid 351767220)
8. GA Colditz B Rosner 2000 Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study Am J Epidemiol 152 10 950 964 11092437 10.1093/aje/152.10.950 1:STN:280: DC%2BD3M%2FmvVeqtQ%3D%3D
9. GA Colditz BA Rosner WY Chen MD Holmes SE Hankinson 2004 Risk factors for breast cancer according to estrogen and progesterone receptor status J Natl Cancer Inst 96 3 218 228 14759989 10.1093/jnci/djh025 1:CAS:528: DC%2BD2cXhtVKkurg%3D (Pubitemid 38263181)
10. A Decarli S Calza G Masala C Specchia D Palli MH Gail 2006 Gail model for prediction of absolute risk of invasive breast cancer: independent evaluation in the Florence-European prospective investigation into cancer and nutrition cohort J Natl Cancer Inst 98 23 1686 1693 17148770 10.1093/jnci/djj463 (Pubitemid 44961712)
11. MH Gail LA Brinton DP Byar DK Corle SB Green C Schairer JJ Mulvihill 1989 Projecting individualized probabilities of developing breast cancer for white females who are being examined annually J Natl Cancer Inst 81 24 1879 1886 2593165 10.1093/jnci/81.24.1879 1:STN:280:DyaK3c%2FnvF2kuw%3D%3D (Pubitemid 20026073)
12. EO Lee SH Ahn C You DS Lee W Han KJ Choe DY Noh 2004 Determining the main risk factors and high-risk groups of breast cancer using a predictive model for breast cancer risk assessment in South Korea Cancer Nurs 27 5 400 406 15525868 10.1097/00002820-200409000-00010 (Pubitemid 39346531)
13. B Rosner GA Colditz 1996 Nurses' health study: log-incidence mathematical model of breast cancer incidence J Natl Cancer Inst 88 6 359 364 8609645 10.1093/jnci/88.6.359 1:STN:280:DyaK287psVelsA%3D%3D (Pubitemid 26094243)
14. WE Barlow E White R Ballard-Barbash PM Vacek L Titus-Ernstoff PA Carney JA Tice DS Buist BM Geller R Rosenberg BC Yankaskas K Kerlikowske 2006 Prospective breast cancer risk prediction model for women undergoing screening mammography J Natl Cancer Inst 98 17 1204 1214 10.1093/jnci/djj331 16954473 10.1093/jnci/djj331 (Pubitemid 44390991)
15. J Chen D Pee R Ayyagari B Graubard C Schairer C Byrne J Benichou MH Gail 2006 Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density J Natl Cancer Inst 98 17 1215 1226 16954474 10.1093/jnci/djj332 (Pubitemid 44390992)
16. MH Gail JP Costantino D Pee M Bondy L Newman M Selvan GL Anderson KE Malone PA Marchbanks W McCaskill-Stevens SA Norman MS Simon R Spirtas G Ursin L Bernstein 2007 Projecting individualized absolute invasive breast cancer risk in African American women J Natl Cancer Inst 99 23 1782 1792 18042936 10.1093/jnci/djm223 (Pubitemid 351767204)
17. J Novotny L Pecen L Petruzelka A Svobodnik L Dusek J Danes M Skovajsova 2006 Breast cancer risk assessment in the Czech female population-an adjustment of the original Gail model Breast Cancer Res Treat 95 1 29 35 16319995 10.1007/s10549-005-9027-5 (Pubitemid 43228079)
18. B Rosner GA Colditz JD Iglehart SE Hankinson 2008 Risk prediction models with incomplete data with application to prediction of estrogen receptor-positive breast cancer: prospective data from the Nurses' Health Study Breast Cancer Res BCR 10 4 R55 10.1186/bcr2110
19. Tamimi RM, Rosner B, Colditz GA Evaluation of a breast cancer risk prediction model expanded to include category of prior benign breast disease lesion. Cancer. doi: 10.1002/cncr.25386
20. JA Tice SR Cummings R Smith-Bindman L Ichikawa WE Barlow K Kerlikowske 2008 Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model Ann Intern Med 148 5 337 347 18316752 (Pubitemid 351665464)
21. JA Tice SR Cummings E Ziv K Kerlikowske 2005 Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population Breast Cancer Res Treat 94 2 115 122 16261410 10.1007/s10549-005-5152-4 (Pubitemid 41547108)
22. JA Tice R Miike K Adduci NL Petrakis E King MR Wrensch 2005 Nipple aspirate fluid cytology and the Gail model for breast cancer risk assessment in a screening population Cancer Epidemiol Biomarkers Prev 14 2 324 328 15734953 10.1158/1055-9965.EPI-04-0289 (Pubitemid 40270092)
23. K Ueda H Tsukuma H Tanaka W Ajiki A Oshima 2003 Estimation of individualized probabilities of developing breast cancer for Japanese women Breast cancer (Tokyo, Japan) 10 1 54 62 10.1007/BF02967626
24. ML Bondy ED Lustbader S Halabi E Ross VG Vogel 1994 Validation of a breast cancer risk assessment model in women with a positive family history J Natl Cancer Inst 86 8 620 625 8003106 10.1093/jnci/86.8.620 1:STN:280: DyaK2c7psVGntg%3D%3D (Pubitemid 24143172)
25. JP Costantino MH Gail D Pee S Anderson CK Redmond J Benichou HS Wieand 1999 Validation studies for models projecting the risk of invasive and total breast cancer incidence J Natl Cancer Inst 91 18 1541 1548 10491430 10.1093/jnci/91.18.1541 1:STN:280:DyaK1Mvitlyguw%3D%3D (Pubitemid 29457958)
26. KP McKian CA Reynolds DW Visscher A Nassar DC Radisky RA Vierkant AC Degnim JC Boughey K Ghosh SS Anderson D Minot JL Caudill CM Vachon MH Frost VS Pankratz LC Hartmann 2009 Novel breast tissue feature strongly associated with risk of breast cancer J Clin Oncol 27 35 5893 5898 19805686 10.1200/JCO.2008.21. 5079
27. B Rockhill C Byrne B Rosner MM Louie G Colditz 2003 Breast cancer risk prediction with a log-incidence model: evaluation of accuracy J Clin Epidemiol 56 9 856 861 14505770 10.1016/S0895-4356(03)00124-0 (Pubitemid 37162659)
28. B Rockhill D Spiegelman C Byrne DJ Hunter GA Colditz 2001 Validation of the Gail et al. Model of breast cancer risk prediction and implications for chemoprevention J Natl Cancer Inst 93 5 358 366 11238697 10.1093/jnci/93.5.358 1:STN:280:DC%2BD3M7pvVWruw%3D%3D (Pubitemid 32229380)
29. Schonfeld SJ, Pee D, Greenlee RT, Hartge P, Lacey JV, Jr., Park Y, Schatzkin A, Visvanathan K, Pfeiffer RM (2010) Effect of changing breast cancer incidence rates on the calibration of the Gail model. J Clin Oncol 28(14):2411-2417. doi: 10.1200/JCO.2009.25.2767
30. C Ulusoy I Kepenekci K Kose S Aydintug R Cam 2010 Applicability of the Gail model for breast cancer risk assessment in Turkish female population and evaluation of breastfeeding as a risk factor Breast Cancer Res Treat 120 2 419 424 19760030 10.1007/s10549-009-0541-8
31. EW Steyerberg AJ Vickers NR Cook T Gerds M Gonen N Obuchowski MJ Pencina MW Kattan 2010 Assessing the performance of prediction models: a framework for traditional and novel measures Epidemiology 21 1 128 138 10.1097/EDE. 0b013e3181c30fb2 20010215 10.1097/EDE.0b013e3181c30fb2
32. AJ Vickers AM Cronin 2010 Traditional statistical methods for evaluating prediction models are uninformative as to clinical value: towards a decision analytic framework Semin Oncol 37 1 31 38 10.1053/j.seminoncol.2009.12.004 20172362 10.1053/j.seminoncol.2009.12.004
33. MJ Pencina RB D'Agostino Sr RB D'Agostino Jr RS Vasan 2008 Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2 157 172 17569110 10.1002/sim.2929 discussion 207-112 (Pubitemid 351193639)
34. DG Altman P Royston 2000 What do we mean by validating a prognostic model? Stat Med 19 4 453 473 10694730 10.1002/(SICI)1097-0258(20000229)19: 4<453::AID-SIM350>3.0.CO;2-5 1:STN:280:DC%2BD3c7mtV2ltQ%3D%3D (Pubitemid 30126878)
35. P Peduzzi J Concato AR Feinstein TR Holford 1995 Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates J Clin Epidemiol 48 12 1503 1510 8543964 10.1016/0895-4356(95)00048-8 1:STN:280:DyaK287js1Wmsg%3D%3D (Pubitemid 26035533)
36. DS Courvoisier C Combescure T Agoritsas A Gayet-Ageron TV Perneger 2011 Performance of logistic regression modeling: beyond the number of events per variable, the role of data structure J Clin Epidemiol 64 9 993 1000 10.1016/j.jclinepi.2010.11.012 21411281 10.1016/j.jclinepi.2010.11.012
37. MS Pepe H Janes G Longton W Leisenring P Newcomb 2004 Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker Am J Epidemiol 159 9 882 890 15105181 10.1093/aje/kwh101 (Pubitemid 38657490)
38. Haynes RB, Sackett DL, Guyatt GH (eds) (2006) Clinical epidemiology: how to do clinical practice research, 3rd edn. Lippincott Williams and Wilkins, Philadelphia
39. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer (1997). Lancet 350(9084):1047-1059
40. M Ewertz SW Duffy HO Adami G Kvale E Lund O Meirik A Mellemgaard I Soini H Tulinius 1990 Age at first birth, parity and risk of breast cancer: A meta-analysis of 8 studies from the Nordic countries Int J Cancer 46 4 597 603 2145231 10.1002/ijc.2910460408 1:STN:280:DyaK3M%2Fgsl2rsg%3D%3D (Pubitemid 20355746)
41. PD Pharoah NE Day S Duffy DF Easton BA Ponder 1997 Family history and the risk of breast cancer: a systematic review and meta-analysis Int J Cancer 71 5 800 809 9180149 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.0. CO;2-B 1:STN:280:DyaK2szitl2msQ%3D%3D (Pubitemid 27237202)
42. North RA, McCowan LME, Dekker GA, Poston L, Chan EHY, Stewart AW, Black MA, Taylor RS, Walker JJ, Baker PN, Kenny LC (2011) Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort. BMJ (Clinical research ed) 342:d1875s. doi: 10.1136/bmj.d1875
43. J Tyrer SW Duffy J Cuzick 2004 A breast cancer prediction model incorporating familial and personal risk factors Stat Med 23 7 1111 1130 15057881 10.1002/sim.1668 (Pubitemid 38477070)
44. E Amir DG Evans A Shenton F Lalloo A Moran C Boggis M Wilson A Howell 2003 Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme J Med Genet 40 11 807 814 14627668 10.1136/jmg.40.11.807 1:STN:280:DC%2BD3srkvFartg%3D%3D (Pubitemid 37485490)
45. NR Cook 2007 Use and misuse of the receiver operating characteristic curve in risk prediction Circulation 115 7 928 935 10.1161/CIRCULATIONAHA.106. 672402 17309939 10.1161/CIRCULATIONAHA.106.672402 (Pubitemid 46294733)
46. NR Cook JE Buring PM Ridker 2006 The effect of including C-reactive protein in cardiovascular risk prediction models for women Ann Intern Med 145 1 21 29 16818925 1:CAS:528:DC%2BD28XnslKhtL4%3D (Pubitemid 46780601)
47. H Janes MS Pepe W Gu 2008 Assessing the value of risk predictions by using risk stratification tables Ann Intern Med 149 10 751 760 19017593
48. LM McShane DG Altman W Sauerbrei SE Taube M Gion GM Clark 2005 Reporting recommendations for tumor marker prognostic studies (REMARK) J Natl Cancer Inst 97 16 1180 1184 10.1093/jnci/dji237 16106022 10.1093/jnci/dji237 1:CAS:528:DC%2BD2MXpsVaks7s%3D (Pubitemid 41258223)